Collaborate Explore Discover

Investigator Title Start DateSalgia, RaviSolway, JulianZhao, YinmingGreene, GeoffreyFerguson, EdwinSalgia, RaviNash, PiersKron, StephenKoide, ShoheiSalgia, RaviSalgia, RaviLengyel, ErnstRinker-Schaeffer,CarrieBoone, DavidSolway, JulianHaydon, RexRole of c-Met in SCLC and Potentialfor Novel TherapyEvaluation of Lovastatin in SeverePersistent Asthma (ElisPA)A Novel Proteomics Technology forProtein FarnesylationStructure-Function Analysis of ERAlpha/Beta Bound to Bazedoxifene/CEMixturesCharacterization of the Interactionsbetween a Stem Cell and its Niche InDrosophillaPhase I Safety, Pharmacokinetic andPharmacodynamic Study of PF-04217903 in Patients with AdvancedCancerProtein-protein Interactions in SignalTransductionMALDI Imaging of Cancer SignalingSignaturesHigh-Performance Affinity Reagentsfor Peptide EpitopesNovel Targeted Therapy in PancreaticCancerA Phase I Followed by a Randomized,Phase II Study of Carboplatin andEtoposide With or Without ObatoclaxAdministered Every 3 Weeks toPatients with Extensive State SmallCell Lung CancerDevelopment of Novel Therapeuticand Diagnostic Strategies for OvarianCancerIdentification of Effectors of MKK4-Mediated Suppression oin OvarianCancer Metastatic ColonizationFunctional Consequences ofAutophagy Mutations in Crohn’sDiseaseThe Influence of Budesonide andFormoterol on Force Fluctuation-Induced Relengthening of ContractedAirway Smooth MuscleSynergistic Use of Oteogenic BMP’s ina New Zealand White Rabbit Model ofSpine FusionEndDateAnnualTotal CostClassFunding Agency9/19/2008 2/28/2013 $251,380 R01 National Cancer Institute9/5/2008 8/31/2009 $231,000 R34National Institute of Allergyand Infectious Diseases1/16/2009 3/31/2010 $230,949 R33 National Cancer Institute4/25/2008 4/24/2009 $230,545 N/A1/1/2008 12/31/2011 $230,250 SSWyeth-AyerstPharmaceuticalsThe Ellison MedicalFoundation7/9/2008 7/8/2010 $208,209 N/A Pfizer, Inc.9/1/2008 8/31/2009 $180,562 N/A National Science Foundation7/16/2008 6/30/2010 $172,687 R21 National Cancer Institute4/4/2008 3/31/2010 $168,065 R21 National Cancer Institute3/1/2009 2/28/2011 $156,000 R21 National Cancer Institute5/28/2008 5/27/2010 $152,694 N/AGemin X BiotechnologiesInc.7/1/2008 6/30/2013 $150,000 N/A Burroughs Wellcome Fund6/1/2008 5/31/2009 $145,433 N/A Pardee Foundation, Elsa U.12/1/2008 11/30/2009 $139,274 N/A4/28/2008 4/27/2010 $126,906 N/A Astrazeneca1/1/2009 12/31/2009 $124,496 N/AKron, Stephen Chicago Laminome Project 11/1/2008 10/31/2010 $120,000 N/AMrksich, MilanSalgia, RaviRosner, MarshaCollaborative Proposal: EMT/MISC:Behavior Based Molecular RoboticsExpression and Function of the RONReceptor Tyrosine KinaseRegulation of Breast Cancer StemCells by Raf Kinase Inhibitory ProteinBroad Foundation, The Eliand Edythe L.Musculoskeletal TransplantFoundationThe Searle Funds at theChicago Community Trust9/1/2008 8/31/2011 $105,000 N/A National Science Foundation5/22/2008 5/21/2009 $100,000 N/A Biogen Idec Inc.1/1/2009 12/31/2009 $100,000 N/A Geyer Foundation, CharlotteCell Signaling &Gene RegulationUCCRC SCIENTIFIC REPORT 200927